Cognex Co. (NASDAQ:CGNX) – Stock analysts at Northcoast Research lowered their Q2 2020 earnings per share estimates for shares of Cognex in a report released on Tuesday, July 28th. Northcoast Research analyst T. Hayes now anticipates that the scientific and technical instruments company will earn $0.11 per share for the quarter, down from their previous forecast of $0.12. Northcoast Research also issued estimates for Cognex’s FY2020 earnings at $0.54 EPS, Q2 2021 earnings at $0.24 EPS and FY2021 earnings at $0.92 EPS.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Wednesday, July 29th. The scientific and technical instruments company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.11). The company had revenue of $169.10 million for the quarter, compared to analyst estimates of $149.90 million. Cognex had a return on equity of 10.67% and a net margin of 20.50%. The firm’s quarterly revenue was down 15.0% on a year-over-year basis. During the same quarter last year, the company posted $0.27 earnings per share.

A number of other research firms also recently weighed in on CGNX. UBS Group increased their price objective on Cognex from $43.00 to $56.00 and gave the company a “neutral” rating in a report on Friday, May 8th. restated a “sell” rating on shares of Cognex in a report on Tuesday, June 9th. BidaskClub upgraded Cognex from a “buy” rating to a “strong-buy” rating in a report on Wednesday. Robert W. Baird downgraded Cognex from a “neutral” rating to an “underperform” rating and increased their price objective for the company from $44.00 to $45.00 in a report on Tuesday, June 2nd. Finally, HSBC assumed coverage on Cognex in a report on Monday, May 25th. They issued a “hold” rating and a $55.00 price objective for the company. Five investment analysts have rated the stock with a sell rating, six have issued a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $53.40.

NASDAQ CGNX opened at $66.87 on Friday. The company has a market capitalization of $11.57 billion, a price-to-earnings ratio of 82.56 and a beta of 1.79. Cognex has a twelve month low of $35.20 and a twelve month high of $66.95. The stock has a fifty day simple moving average of $60.53 and a 200 day simple moving average of $53.68. The company has a quick ratio of 3.59, a current ratio of 4.47 and a debt-to-equity ratio of 0.02.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Friday, August 14th will be given a dividend of $0.055 per share. The ex-dividend date of this dividend is Thursday, August 13th. This represents a $0.22 dividend on an annualized basis and a dividend yield of 0.33%. Cognex’s dividend payout ratio (DPR) is presently 18.97%.

Hedge funds have recently added to or reduced their stakes in the company. Wells Fargo & Company MN boosted its position in shares of Cognex by 0.5% during the 1st quarter. Wells Fargo & Company MN now owns 230,462 shares of the scientific and technical instruments company’s stock worth $9,730,000 after purchasing an additional 1,070 shares in the last quarter. Beese Fulmer Investment Management Inc. bought a new position in shares of Cognex during the 2nd quarter worth about $72,000. Strs Ohio boosted its position in shares of Cognex by 1,075.1% during the 2nd quarter. Strs Ohio now owns 24,877 shares of the scientific and technical instruments company’s stock worth $1,485,000 after purchasing an additional 22,760 shares in the last quarter. Smithfield Trust Co. boosted its position in shares of Cognex by 348.3% during the 1st quarter. Smithfield Trust Co. now owns 1,345 shares of the scientific and technical instruments company’s stock worth $56,000 after purchasing an additional 1,045 shares in the last quarter. Finally, NN Investment Partners Holdings N.V. bought a new position in shares of Cognex during the 2nd quarter worth about $1,696,000. 93.97% of the stock is currently owned by institutional investors.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Recommended Story: What is a Fiduciary?

Earnings History and Estimates for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.